7Baggers
 published on: 2025-10-02 20:16:34  newser.com Fri, 03 Oct 2025 01:16:34 GMT
 CRISPR Therapies Clinical Trial Pipeline Shows Potential  GlobeNewswire Thu, 02 Oct 2025 17:02:51 GMT
 H.C. Wainwright Genetic Medicines Virtual Conference  Intellia Therapeutics Wed, 01 Oct 2025 15:24:23 GMT
 Cathie Wood Goes Shopping: 3 Rising Stocks She Just Bought  Yahoo Finance Wed, 01 Oct 2025 14:47:00 GMT
 u.s. gene editing market projections 2025-2032: key trends,  openPR.com Wed, 01 Oct 2025 05:03:59 GMT
 Intellia Therapeutics (NTLA): ARK Investment Acquires 99K Shares  GuruFocus Wed, 01 Oct 2025 01:41:15 GMT
 published on: 2025-09-30 20:11:05  newser.com Wed, 01 Oct 2025 01:11:05 GMT
 Intellia Therapeutics (NTLA) Receives a Buy from TD Cowen  The Globe and Mail Sat, 27 Sep 2025 07:04:00 GMT
 Intellia Therapeutics Announces Positive Phase 1 Trial Results  The Globe and Mail Fri, 26 Sep 2025 20:54:00 GMT
 td cowen maintains intellia therapeutics(ntla.us) with buy rating  富途牛牛 Fri, 26 Sep 2025 07:33:00 GMT
 Intellia Therapeutics Announces Positive Phase 1 Trial Results  TipRanks Thu, 25 Sep 2025 20:54:55 GMT
 Intellia Therapeutics (NTLA) Shares Positive Phase 1 Trial Resul  GuruFocus Thu, 25 Sep 2025 15:24:32 GMT
 intellia therapeutics (nasdaq:ntla) shares up 8% - what's next?  MarketBeat Wed, 24 Sep 2025 16:47:31 GMT
 intellia to present data on crispr therapy for attr amyloidosis by investing.com  Investing.com Nigeria Tue, 23 Sep 2025 09:32:01 GMT
 Stocks Flashing Renewed Technical Strength: Intellia Therapeutics  Investor's Business Daily Tue, 23 Sep 2025 07:00:00 GMT
 global clinical trial of hae gene-editing therapy now fully enrolled  Angioedema News Mon, 22 Sep 2025 13:02:02 GMT
 cathie wood's ark innovation etf expands holdings in intellia th  GuruFocus Mon, 22 Sep 2025 11:01:04 GMT
 Intellia Therapeutics to Present Longer-Term Data from the  GlobeNewswire Mon, 22 Sep 2025 07:00:00 GMT
 intellia to present data on crispr therapy for attr amyloidosis  Investing.com Mon, 22 Sep 2025 07:00:00 GMT
 intellia therapeutics (nasdaq:ntla) shares gap up - what's next?  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 citizens jmp remains a hold on intellia therapeutics (ntla)  The Globe and Mail Sat, 20 Sep 2025 12:46:00 GMT
 intellia therapeutics (nasdaq:ntla) shares up 6.3% - time to buy?  MarketBeat Sat, 20 Sep 2025 07:00:00 GMT
 why intellia ($ntla) just had a major breakout  MSN Fri, 19 Sep 2025 20:32:49 GMT
 ntla completes enrollment in pivotal study on hae candidate, stock up  Yahoo Finance Fri, 19 Sep 2025 16:24:00 GMT
 ntla: hc wainwright & co. raises price target to $30 | ntla stoc  GuruFocus Fri, 19 Sep 2025 12:47:48 GMT
 genome editing market: strategic growth and investment  openPR.com Fri, 19 Sep 2025 10:07:11 GMT
 intellia therapeutics completes enrollment in the global  GlobeNewswire Fri, 19 Sep 2025 09:29:29 GMT
 Intellia Therapeutics Scores Relative Strength Rating Upgrade  Investor's Business Daily Fri, 19 Sep 2025 07:00:00 GMT
 intellia completes enrollment in phase 3 hae gene therapy trial  Investing.com India Thu, 18 Sep 2025 16:48:55 GMT
 intellia therapeutics (nasdaq:ntla) shares gap up - still a buy?  MarketBeat Thu, 18 Sep 2025 16:38:12 GMT
 intellia therapeutics (ntla) completes enrollment for phase 3 st  GuruFocus Thu, 18 Sep 2025 12:09:11 GMT
 Intellia Therapeutics Shares Are Ripping Higher: Here's Why  Benzinga Thu, 18 Sep 2025 07:00:00 GMT
 Intellia Therapeutics Completes Enrollment in the Global  GlobeNewswire Thu, 18 Sep 2025 07:00:00 GMT
 intellia therapeutics (ntla) surges 20% on trial enrollment comp  GuruFocus Thu, 18 Sep 2025 07:00:00 GMT
 intellia stock rises after completing enrollment in phase 3 hae study  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 intellia rises after completion of enrollment in angioedema study  Seeking Alpha Thu, 18 Sep 2025 07:00:00 GMT
 gene editing market exclusive report with detailed study &  openPR.com Wed, 17 Sep 2025 09:11:01 GMT
 published on: 2025-09-16 17:59:37  khodrobank.com Tue, 16 Sep 2025 14:30:55 GMT
 analyst upgrade: can intellia therapeutics inc. grow without dilution  خودرو بانک Tue, 16 Sep 2025 02:58:19 GMT
 biomedical crispr gene editing market to see booming growth  openPR.com Mon, 15 Sep 2025 12:49:14 GMT
 zacks research issues optimistic outlook for ntla earnings  MarketBeat Mon, 15 Sep 2025 07:00:00 GMT
 three crispr stocks you can’t afford to miss  NAI500 Mon, 15 Sep 2025 03:12:48 GMT
 q3 eps estimate for intellia therapeutics raised by analyst  MarketBeat Sun, 14 Sep 2025 20:06:25 GMT
 three crispr stocks you can’t afford to miss  NAI500 Sun, 14 Sep 2025 07:00:00 GMT
 zacks research analysts increase earnings estimates for ntla  MarketBeat Fri, 12 Sep 2025 12:23:02 GMT
 zacks research has optimistic outlook of ntla q3 earnings  MarketBeat Fri, 12 Sep 2025 12:23:02 GMT
 zacks research issues positive outlook for ntla earnings  MarketBeat Fri, 12 Sep 2025 12:23:02 GMT
 intellia therapeutics (nasdaq:ntla) upgraded at wall street zen  MarketBeat Thu, 11 Sep 2025 00:10:23 GMT
 intellia therapeutics (nasdaq:ntla) upgraded at wall street zen  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 intellia therapeutics (nasdaq:ntla) trading up 7.5% - what's next?  MarketBeat Tue, 09 Sep 2025 00:00:00 GMT
 intellia therapeutics (nasdaq:ntla) trading up 7.5% - what's next?  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 05:28:03  Newser Fri, 05 Sep 2025 10:28:03 GMT
 ark investment expands stake in intellia therapeutics (ntla)  GuruFocus Fri, 05 Sep 2025 00:26:11 GMT
 beat the market the zacks way: oracle, intellia, pharming group in focus  Zacks Investment Research Tue, 02 Sep 2025 12:17:51 GMT
 Stocks With Rising Relative Strength: Intellia Therapeutics  Investor's Business Daily Tue, 02 Sep 2025 07:00:00 GMT
 Why big players are pouring millions in THIS biotech stock  TradingView Mon, 01 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 12:27:32  Newser Sun, 31 Aug 2025 17:27:32 GMT

Intellia Therapeutics, Inc
(NASDAQ:NTLA) 

NTLA stock logo

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. The company's in vivo programs include NTLA-2001, which i...

Founded: 2014
Full Time Employees: 270
CEO: John Leonard  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends